TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a bioactive coating aimed at enhancing the interaction between titanium orthopedic implants and bone tissue. The coating incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds linked to nitric oxide synthesis. Laboratory experiments revealed a notably higher survival rate of human mesenchymal stem cells on the coated surfaces compared to uncoated titanium. The team investigated the coating’s structural, chemical, mechanical, and biological attributes. Their peer-reviewed results were published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, scientists produced these experimental coatings through reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. During deposition, they adjusted the nitrogen to argon ratio to observe how each mixture influenced the surface properties. The study examined five different conditions, from pure nitrogen to pure argon. They measured parameters such as coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, laboratory tests assessed how living human cells responded to the modified titanium surfaces.
The experiments indicated that the amount of argon impacted several physical characteristics of the coatings. Surfaces created in pure argon were found to be denser and harder than those formed in pure nitrogen. An increase in argon proportion also led to thicker coatings. Chemical analysis detected nitrogen-carbon and nitrogen-oxygen bonds on the surfaces. Researchers then compared human mesenchymal stem cells cultivated on coated titanium with those on uncoated titanium. The biological assessments focused on cell viability and markers associated with bone-cell differentiation.
Enhanced Cell Survival Observed in Coating Tests
Cell testing demonstrated significantly improved survival rates on coated surfaces compared to uncoated titanium, as reported in the findings. After a seven-day period, coatings with higher nitrogen content also showed reduced activity in certain genes related to early bone-cell differentiation. Despite this, the cells maintained their ability to form bone tissue. The research evaluated these effects under controlled laboratory conditions using human mesenchymal stem cells, but the study did not involve clinical trials or testing in patients with implanted devices.
The biomedical evaluation was conducted by Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional participation from Saint Petersburg State University. The project received support through Russia’s national science program. The researchers aimed to identify gas mixtures capable of producing favorable combinations of physical, chemical, and biological coating properties. Hydroxyapatite, due to its calcium phosphate composition, already has established uses in implant coatings because it closely resembles the mineral component of human bone.
Current Research Remains at the Laboratory Stage
The research team plans to extend testing beyond the initial seven-day cell evaluation. They intend to analyze stem cell responses over periods ranging from 10 to 28 days and investigate the rate of coating dissolution. Additionally, future studies will measure nitric oxide release into surrounding tissue in vivo, though these investigations were not part of the current publication. The present research focuses on coated titanium substrates, material properties, and in vitro cell responses, rather than clinical outcomes in orthopedic patients.
The results offer comprehensive laboratory data on how nitrogen and argon ratios influence calcium phosphate coatings applied to titanium surfaces. Variations in thickness, density, hardness, chemical bonding, and cellular response across different gas mixtures are documented. The study also confirms that coated samples support higher stem-cell survival than uncoated titanium under laboratory conditions. Nonetheless, as a preclinical investigation, these experiments do not establish safety or efficacy for human use. Additional biological testing will be necessary to evaluate properties not covered in this initial study.